154 related articles for article (PubMed ID: 18655774)
1. Modulation of PLAGL2 transactivation activity by Ubc9 co-activation not SUMOylation.
Guo Y; Yang MC; Weissler JC; Yang YS
Biochem Biophys Res Commun; 2008 Sep; 374(3):570-5. PubMed ID: 18655774
[TBL] [Abstract][Full Text] [Related]
2. PLAGL2 translocation and SP-C promoter activity--a cellular response of lung cells to hypoxia.
Guo Y; Yang MC; Weissler JC; Yang YS
Biochem Biophys Res Commun; 2007 Aug; 360(3):659-65. PubMed ID: 17618602
[TBL] [Abstract][Full Text] [Related]
3. Tip60 modulates PLAGL2-mediated transactivation by acetylation.
Ning J; Zheng G; Yang YC
J Cell Biochem; 2008 Feb; 103(3):730-9. PubMed ID: 17551969
[TBL] [Abstract][Full Text] [Related]
4. Ubc9 and Protein Inhibitor of Activated STAT 1 Activate Chicken Ovalbumin Upstream Promoter-Transcription Factor I-mediated Human CYP11B2 Gene Transcription.
Kurihara I; Shibata H; Kobayashi S; Suda N; Ikeda Y; Yokota K; Murai A; Saito I; Rainey WE; Saruta T
J Biol Chem; 2005 Feb; 280(8):6721-30. PubMed ID: 15611122
[TBL] [Abstract][Full Text] [Related]
5. Repression of the Transactivating Capacity of the Oncoprotein PLAG1 by SUMOylation.
Van Dyck F; Delvaux EL; Van de Ven WJ; Chavez MV
J Biol Chem; 2004 Aug; 279(34):36121-31. PubMed ID: 15208321
[TBL] [Abstract][Full Text] [Related]
6. Pleiomorphic adenoma gene-like-2, a zinc finger protein, transactivates the surfactant protein-C promoter.
Yang MC; Weissler JC; Terada LS; Deng F; Yang YS
Am J Respir Cell Mol Biol; 2005 Jan; 32(1):35-43. PubMed ID: 15361364
[TBL] [Abstract][Full Text] [Related]
7. A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo.
Antoine K; Prosperi MT; Ferbus D; Boule C; Goubin G
Mol Cell Biochem; 2005 Mar; 271(1-2):215-23. PubMed ID: 15881673
[TBL] [Abstract][Full Text] [Related]
8. A non-covalent interaction between small ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular functions.
Liu ST; Chang YL; Wang WM; Chung MH; Lin WS; Chou WY; Huang SM
Int J Biochem Cell Biol; 2012 Mar; 44(3):547-55. PubMed ID: 22227369
[TBL] [Abstract][Full Text] [Related]
9. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
Zhang J; Goodson ML; Hong Y; Sarge KD
J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
[TBL] [Abstract][Full Text] [Related]
10. Ubc9 interacts with chicken ovalbumin upstream promoter-transcription factor I and represses receptor-dependent transcription.
Kobayashi S; Shibata H; Kurihara I; Yokota K; Suda N; Saito I; Saruta T
J Mol Endocrinol; 2004 Feb; 32(1):69-86. PubMed ID: 14765993
[TBL] [Abstract][Full Text] [Related]
11. Binding of pleomorphic adenoma gene-like 2 to the tumor necrosis factor (TNF)-alpha-responsive region of the NCF2 promoter regulates p67(phox) expression and NADPH oxidase activity.
Ammons MC; Siemsen DW; Nelson-Overton LK; Quinn MT; Gauss KA
J Biol Chem; 2007 Jun; 282(24):17941-52. PubMed ID: 17462995
[TBL] [Abstract][Full Text] [Related]
12. SUMO functions in constitutive transcription and during activation of inducible genes in yeast.
Rosonina E; Duncan SM; Manley JL
Genes Dev; 2010 Jun; 24(12):1242-52. PubMed ID: 20504900
[TBL] [Abstract][Full Text] [Related]
13. Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1.
Kim EJ; Park JS; Um SJ
Biochem Biophys Res Commun; 2008 Dec; 377(3):952-6. PubMed ID: 18955028
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor alpha and nuclear factor Y coordinately regulate the transcription of the SUMO-conjugating UBC9 gene in MCF-7 breast cancer cells.
Ying S; Dünnebier T; Si J; Hamann U
PLoS One; 2013; 8(9):e75695. PubMed ID: 24086615
[TBL] [Abstract][Full Text] [Related]
15. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
[TBL] [Abstract][Full Text] [Related]
16. Modulation of PLAGL2 transactivation by positive cofactor 2 (PC2), a component of the ARC/Mediator complex.
Wezensky SJ; Hanks TS; Wilkison MJ; Ammons MC; Siemsen DW; Gauss KA
Gene; 2010 Feb; 452(1):22-34. PubMed ID: 20025940
[TBL] [Abstract][Full Text] [Related]
17. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor.
Tirard M; Almeida OF; Hutzler P; Melchior F; Michaelidis TM
Mol Cell Endocrinol; 2007 Mar; 268(1-2):20-9. PubMed ID: 17314004
[TBL] [Abstract][Full Text] [Related]
18. Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9.
Yokota K; Shibata H; Kurihara I; Kobayashi S; Suda N; Murai-Takeda A; Saito I; Kitagawa H; Kato S; Saruta T; Itoh H
J Biol Chem; 2007 Jan; 282(3):1998-2010. PubMed ID: 17105732
[TBL] [Abstract][Full Text] [Related]
19. Coactivation of SF-1-mediated transcription of steroidogenic enzymes by Ubc9 and PIAS1.
Suda N; Shibata H; Kurihara I; Ikeda Y; Kobayashi S; Yokota K; Murai-Takeda A; Nakagawa K; Oya M; Murai M; Rainey WE; Saruta T; Itoh H
Endocrinology; 2011 Jun; 152(6):2266-77. PubMed ID: 21467194
[TBL] [Abstract][Full Text] [Related]
20. Regulation of nuclear receptor and coactivator functions by the carboxyl terminus of ubiquitin-conjugating enzyme 9.
Chang YL; Huang CJ; Chan JY; Liu PY; Chang HP; Huang SM
Int J Biochem Cell Biol; 2007; 39(5):1035-46. PubMed ID: 17336575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
